Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (1): 21-33.doi: 10.19982/j.issn.1000-6621.20250315
• Original Articles • Previous Articles Next Articles
Sun Qing, Wang Xiaoping, Yang Xiaomei, Han Ruihao, Gu Yeqiu, Fu Jian(
)
Received:2025-08-01
Online:2026-01-10
Published:2025-12-31
Contact:
Fu Jian, Email:CLC Number:
Sun Qing, Wang Xiaoping, Yang Xiaomei, Han Ruihao, Gu Yeqiu, Fu Jian. Analysis on the current situation and trend of tuberculosis disease burden of people aged ≤24 in China from 2000 to 2021[J]. Chinese Journal of Antituberculosis, 2026, 48(1): 21-33. doi: 10.19982/j.issn.1000-6621.20250315
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250315
| 年份 | 发病率 | 感染率 | 死亡率 | DALYs率 | 年份 | 发病率 | 感染率 | 死亡率 | DALYs率 |
|---|---|---|---|---|---|---|---|---|---|
| 2000 | 79.15 | 32422.78 | 10.30 | 374.96 | 2012 | 49.33 | 29292.10 | 3.34 | 128.45 |
| 2001 | 75.73 | 32027.97 | 9.77 | 352.40 | 2013 | 46.01 | 28667.66 | 3.06 | 117.78 |
| 2002 | 71.94 | 31284.17 | 9.34 | 331.84 | 2014 | 43.16 | 28144.18 | 2.84 | 109.29 |
| 2003 | 68.18 | 30438.99 | 8.93 | 311.30 | 2015 | 41.42 | 27918.13 | 2.72 | 104.30 |
| 2004 | 64.87 | 29742.72 | 8.38 | 289.53 | 2016 | 40.62 | 28310.15 | 2.60 | 100.06 |
| 2005 | 62.44 | 29446.97 | 7.53 | 259.64 | 2017 | 40.06 | 29196.21 | 2.41 | 94.03 |
| 2006 | 60.71 | 29507.71 | 6.30 | 224.55 | 2018 | 39.57 | 30105.43 | 2.25 | 88.80 |
| 2007 | 59.23 | 29666.79 | 5.48 | 199.23 | 2019 | 39.00 | 30567.83 | 2.10 | 84.08 |
| 2008 | 57.84 | 29856.37 | 4.91 | 181.14 | 2020 | 37.88 | 30533.08 | 2.00 | 80.21 |
| 2009 | 56.42 | 30009.22 | 4.38 | 164.50 | 2021 | 36.28 | 30557.45 | 1.91 | 76.22 |
| 2010 | 54.83 | 30057.59 | 3.95 | 149.83 | 均值 | 53.51 | 29889.73 | 4.92 | 180.04 |
| 2011 | 52.48 | 29820.63 | 3.62 | 138.67 | 变化率(%) | -54.16 | -5.75 | -81.46 | -79.67 |
| 分类/年份 | APC值 (%) | 95%CI值 (%) | t值 | P值 | AAPC值 (%) | 95%CI值 (%) | t值 | P值 |
|---|---|---|---|---|---|---|---|---|
| 发病率 | -3.639 | -3.742~-3.536 | -68.120 | <0.001 | ||||
| 2000—2005 | -4.746 | -4.894~-4.600 | -71.825 | <0.001 | ||||
| 2005—2010 | -2.350 | -2.565~-2.134 | -24.839 | <0.001 | ||||
| 2010—2015 | -5.703 | -5.910~-5.494 | -61.333 | <0.001 | ||||
| 2015—2019 | -1.265 | -1.609~-0.920 | -8.409 | <0.001 | ||||
| 2019—2021 | -3.535 | -4.206~-2.860 | -11.888 | <0.001 | ||||
| 感染率 | -0.301 | -0.452~-0.150 | -3.904 | <0.001 | ||||
| 2000—2005 | -2.054 | -2.271~-1.837 | -21.623 | <0.001 | ||||
| 2005—2010 | 0.587 | 0.272~0.902 | 4.310 | 0.003 | ||||
| 2010—2015 | -1.643 | -1.951~-1.335 | -12.204 | <0.001 | ||||
| 2015—2019 | 2.483 | 1.977~2.991 | 11.424 | <0.001 | ||||
| 2019—2021 | -0.200 | -1.183~0.793 | -0.465 | 0.654 | ||||
| 死亡率 | -7.745 | -8.141~-7.346 | -36.670 | <0.001 | ||||
| 2000—2004 | -4.744 | -5.767~-3.710 | -9.911 | <0.001 | ||||
| 2004—2008 | -13.226 | -14.695~-11.733 | -18.297 | <0.001 | ||||
| 2008—2013 | -8.707 | -9.687~-7.716 | -18.576 | <0.001 | ||||
| 2013—2021 | -5.770 | -6.121~-5.419 | -35.128 | <0.001 | ||||
| DALYs率 | -7.317 | -7.588~-7.045 | -50.862 | <0.001 | ||||
| 2000—2004 | -6.117 | -6.550~-5.681 | -31.473 | <0.001 | ||||
| 2004—2007 | -11.963 | -13.241~-10.666 | -20.092 | <0.001 | ||||
| 2007—2010 | -9.052 | -10.372~-7.712 | -14.961 | <0.001 | ||||
| 2010—2014 | -7.475 | -8.149~-6.796 | -24.503 | <0.001 | ||||
| 2014—2021 | -5.089 | -5.274~-4.903 | -61.631 | <0.001 |
| 年份 | 发病率 | 感染率 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0~4岁 | 5~9岁 | 10~14岁 | 15~19岁 | 20~24岁 | 合计 | 0~4岁 | 5~9岁 | 10~14岁 | 15~19岁 | 20~24岁 | 合计 | |
| 2000 | 45.63 | 15.16 | 31.66 | 65.27 | 68.69 | 79.15 | 11118.99 | 5782.76 | 13252.06 | 28175.00 | 36361.37 | 32422.78 |
| 2001 | 42.18 | 15.25 | 30.27 | 62.28 | 65.88 | 75.73 | 10524.41 | 5891.58 | 12869.60 | 27645.33 | 35968.44 | 32027.97 |
| 2002 | 37.65 | 15.53 | 29.08 | 58.92 | 62.51 | 71.94 | 9706.47 | 6166.15 | 12475.02 | 26689.73 | 34978.29 | 31284.17 |
| 2003 | 32.91 | 15.86 | 28.04 | 55.63 | 59.15 | 68.18 | 8858.19 | 6509.03 | 12124.33 | 25611.29 | 33779.82 | 30438.99 |
| 2004 | 28.99 | 16.10 | 27.08 | 52.83 | 56.33 | 64.87 | 8199.52 | 6822.92 | 11871.28 | 24716.49 | 32763.56 | 29742.72 |
| 2005 | 26.79 | 16.12 | 26.16 | 50.94 | 54.57 | 62.44 | 7941.26 | 7010.40 | 11768.47 | 24312.79 | 32324.53 | 29466.97 |
| 2006 | 25.94 | 15.67 | 25.20 | 49.85 | 53.68 | 60.71 | 7974.79 | 7102.56 | 11842.01 | 24332.31 | 32428.13 | 29507.71 |
| 2007 | 25.33 | 14.74 | 24.18 | 49.04 | 53.08 | 59.23 | 8038.05 | 7189.86 | 12034.05 | 24457.38 | 32692.93 | 29666.79 |
| 2008 | 24.78 | 13.57 | 23.11 | 48.39 | 52.65 | 57.84 | 8103.20 | 7263.25 | 12271.57 | 24615.02 | 33003.55 | 29856.37 |
| 2009 | 24.13 | 12.35 | 21.96 | 47.74 | 52.24 | 56.42 | 8146.16 | 7314.07 | 12478.46 | 24734.41 | 33246.35 | 30009.22 |
| 2010 | 23.20 | 11.30 | 20.74 | 46.98 | 51.74 | 54.83 | 8142.12 | 7334.07 | 12575.43 | 24748.90 | 33308.53 | 30507.59 |
| 2011 | 21.61 | 10.33 | 19.19 | 45.49 | 50.54 | 52.48 | 8095.91 | 7297.15 | 12496.71 | 24491.76 | 32932.54 | 29820.63 |
| 2012 | 19.60 | 9.27 | 17.33 | 43.16 | 48.52 | 49.33 | 8058.28 | 7206.17 | 12288.10 | 23964.56 | 32130.83 | 29292.10 |
| 2013 | 17.61 | 8.27 | 15.49 | 40.53 | 46.25 | 46.01 | 8040.69 | 7096.95 | 12034.77 | 23360.02 | 31185.87 | 28667.66 |
| 2014 | 15.95 | 7.45 | 13.95 | 38.19 | 44.36 | 43.16 | 8022.98 | 7005.25 | 11822.08 | 22870.05 | 30380.65 | 28144.18 |
| 2015 | 15.22 | 6.97 | 13.01 | 36.75 | 43.50 | 41.42 | 8019.25 | 6966.83 | 11735.23 | 22686.91 | 30001.30 | 27918.13 |
| 2016 | 15.31 | 6.74 | 12.54 | 36.07 | 43.56 | 40.62 | 8516.66 | 7261.11 | 12231.34 | 23100.70 | 30381.07 | 28310.15 |
| 2017 | 15.46 | 6.58 | 12.20 | 35.52 | 43.82 | 40.06 | 9578.10 | 7916.29 | 13327.10 | 23980.61 | 31318.44 | 29196.21 |
| 2018 | 15.46 | 6.45 | 11.92 | 34.98 | 44.03 | 39.57 | 10599.80 | 8589.94 | 14445.07 | 24882.41 | 32304.88 | 30105.43 |
| 2019 | 15.24 | 6.33 | 11.66 | 34.33 | 43.91 | 39.00 | 11025.43 | 8937.86 | 15005.36 | 25357.04 | 32830.45 | 30567.83 |
| 2020 | 14.56 | 6.18 | 11.33 | 33.11 | 42.38 | 37.88 | 10936.44 | 8952.15 | 14999.24 | 25323.76 | 32783.68 | 30533.08 |
| 2021 | 12.51 | 5.53 | 10.32 | 31.75 | 41.54 | 36.28 | 10915.42 | 8921.82 | 15001.23 | 25405.96 | 32932.35 | 30557.45 |
| 均值 | 23.46 | 10.99 | 19.84 | 45.35 | 51.04 | 53.51 | 9025.55 | 7297.19 | 12770.39 | 24793.75 | 32728.98 | 29889.73 |
| 变化率 (%) | -72.58 | -63.52 | -67.40 | -51.36 | -39.53 | -54.16 | -1.83 | 52.28 | 13.20 | -9.83 | -9.43 | -5.75 |
| 年份 | 死亡率 | DALYs率 | ||||||||||
| 0~4岁 | 5~9岁 | 10~14岁 | 15~19岁 | 20~24岁 | 合计 | 0~4岁 | 5~9岁 | 10~14岁 | 15~19岁 | 20~24岁 | 合计 | |
| 2000 | 6.41 | 0.92 | 0.72 | 1.26 | 2.45 | 10.30 | 601.70 | 85.68 | 59.62 | 123.22 | 216.05 | 374.96 |
| 2001 | 5.81 | 0.83 | 0.66 | 1.15 | 2.29 | 9.77 | 545.99 | 78.83 | 55.06 | 114.13 | 203.80 | 352.40 |
| 2002 | 5.20 | 0.72 | 0.60 | 1.03 | 2.01 | 9.34 | 488.52 | 69.62 | 50.16 | 103.78 | 181.95 | 331.84 |
| 2003 | 4.46 | 0.62 | 0.55 | 0.92 | 1.81 | 8.93 | 419.85 | 60.76 | 45.66 | 93.83 | 165.23 | 311.30 |
| 2004 | 3.81 | 0.54 | 0.50 | 0.83 | 1.66 | 8.38 | 360.26 | 54.43 | 41.49 | 85.60 | 152.21 | 289.53 |
| 2005 | 3.23 | 0.49 | 0.43 | 0.73 | 1.36 | 7.53 | 307.17 | 49.74 | 36.40 | 76.85 | 130.02 | 259.64 |
| 2006 | 2.72 | 0.40 | 0.38 | 0.64 | 1.14 | 6.30 | 261.18 | 42.59 | 32.19 | 69.23 | 114.54 | 224.55 |
| 2007 | 2.28 | 0.33 | 0.34 | 0.56 | 0.97 | 5.48 | 221.61 | 36.35 | 28.51 | 63.00 | 103.09 | 199.23 |
| 2008 | 1.93 | 0.30 | 0.30 | 0.52 | 0.86 | 4.91 | 190.48 | 33.50 | 25.56 | 59.21 | 95.20 | 181.14 |
| 2009 | 1.63 | 0.26 | 0.28 | 0.48 | 0.79 | 4.38 | 163.81 | 29.47 | 24.09 | 55.80 | 90.53 | 164.50 |
| 2010 | 1.34 | 0.20 | 0.25 | 0.42 | 0.75 | 3.95 | 137.73 | 24.23 | 21.11 | 50.85 | 87.25 | 149.83 |
| 2011 | 1.14 | 0.18 | 0.22 | 0.39 | 0.69 | 3.62 | 119.30 | 21.73 | 18.93 | 48.23 | 82.34 | 138.67 |
| 2012 | 1.04 | 0.16 | 0.20 | 0.37 | 0.63 | 3.34 | 108.97 | 19.29 | 16.78 | 45.76 | 77.38 | 128.45 |
| 2013 | 0.95 | 0.13 | 0.17 | 0.34 | 0.59 | 3.06 | 98.62 | 16.52 | 14.83 | 42.45 | 73.81 | 117.78 |
| 2014 | 0.84 | 0.11 | 0.15 | 0.31 | 0.57 | 2.84 | 87.48 | 14.21 | 13.06 | 39.44 | 71.87 | 109.29 |
| 2015 | 0.76 | 0.10 | 0.14 | 0.30 | 0.56 | 2.72 | 79.47 | 12.99 | 11.80 | 38.21 | 71.14 | 104.30 |
| 2016 | 0.68 | 0.09 | 0.12 | 0.29 | 0.55 | 2.60 | 72.39 | 12.22 | 10.72 | 37.37 | 71.20 | 100.06 |
| 2017 | 0.57 | 0.08 | 0.11 | 0.26 | 0.53 | 2.41 | 62.68 | 11.38 | 9.35 | 35.80 | 70.95 | 94.03 |
| 2018 | 0.47 | 0.07 | 0.09 | 0.24 | 0.50 | 2.25 | 54.27 | 10.71 | 8.24 | 34.43 | 70.60 | 88.80 |
| 2019 | 0.38 | 0.06 | 0.08 | 0.22 | 0.47 | 2.10 | 46.68 | 10.02 | 7.33 | 33.07 | 69.29 | 84.08 |
| 2020 | 0.32 | 0.06 | 0.07 | 0.20 | 0.44 | 2.00 | 40.79 | 9.21 | 6.61 | 31.20 | 66.37 | 80.21 |
| 2021 | 0.27 | 0.05 | 0.06 | 0.18 | 0.41 | 1.91 | 34.88 | 7.81 | 5.93 | 28.92 | 63.91 | 76.22 |
| 均值 | 2.10 | 0.31 | 0.29 | 0.53 | 1.00 | 4.92 | 204.72 | 32.33 | 24.70 | 59.56 | 105.85 | 180.04 |
| 变化率 (%) | -95.79 | -94.57 | -91.67 | -85.71 | -83.27 | -81.46 | -94.20 | -90.88 | -90.05 | -76.53 | -70.42 | -79.67 |
| 分类/年龄组/年份 | APC值 (%) | 95%CI值 (%) | t值 | P值 | AAPC值 (%) | 95%CI值 (%) | t值 | P值 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 发病率 | ||||||||||||||||||
| 0~4岁 | -5.970 | -6.543~-5.394 | -19.761 | <0.001 | ||||||||||||||
| 2000—2005 | -10.511 | -11.307~-9.708 | -28.659 | <0.001 | ||||||||||||||
| 2005—2010 | -2.535 | -3.759~-1.296 | -4.686 | 0.002 | ||||||||||||||
| 2010—2015 | -8.504 | -9.653~-7.341 | -16.218 | <0.001 | ||||||||||||||
| 2015—2019 | 1.029 | -0.970~3.068 | 1.182 | 0.271 | ||||||||||||||
| 2019—2021 | -9.770 | -13.305~-6.092 | -5.933 | <0.001 | ||||||||||||||
| 5~9岁 | -4.595 | -5.042~-4.146 | -19.624 | <0.001 | ||||||||||||||
| 2000—2005 | 1.628 | 1.035~2.225 | 6.360 | <0.001 | ||||||||||||||
| 2005—2008 | -5.623 | -8.062~-3.119 | -5.096 | <0.001 | ||||||||||||||
| 2008—2015 | -9.471 | -9.871~-9.069 | -51.839 | <0.001 | ||||||||||||||
| 2015—2019 | -1.741 | -3.019~-0.446 | -3.093 | 0.014 | ||||||||||||||
| 2019—2021 | -6.209 | -8.633~-3.721 | -5.645 | <0.001 | ||||||||||||||
| 10~14岁 | -5.159 | -5.400~-4.917 | -40.744 | <0.001 | ||||||||||||||
| 2000—2010 | -3.982 | -4.117~-3.847 | -63.721 | <0.001 | ||||||||||||||
| 2020—2015 | -9.571 | -10.086~-9.054 | -38.840 | <0.001 | ||||||||||||||
| 2015—2019 | -2.141 | -3.019~-1.254 | -5.283 | <0.001 | ||||||||||||||
| 2019—2021 | -5.649 | -7.335~-3.932 | -7.099 | <0.001 | ||||||||||||||
| 15~19岁 | -3.372 | -3.495~-3.248 | -52.487 | <0.001 | ||||||||||||||
| 2000—2005 | -5.030 | -5.207~-4.851 | -63.484 | <0.001 | ||||||||||||||
| 2005—2010 | -1.278 | -1.540~-1.016 | -11.192 | <0.001 | ||||||||||||||
| 2010—2015 | -4.970 | -5.222~-4.719 | -44.353 | <0.001 | ||||||||||||||
| 2015—2019 | -1.590 | -2.002~-1.177 | -8.817 | <0.001 | ||||||||||||||
| 2019—2021 | -3.867 | -4.670~-3.058 | -10.850 | <0.001 | ||||||||||||||
| 20~24岁 | -2.378 | -2.527~-2.229 | -30.831 | <0.001 | ||||||||||||||
| 2000—2005 | -4.629 | -4.816~-4.441 | -55.680 | <0.001 | ||||||||||||||
| 2005—2011 | -1.020 | -1.214~-0.826 | -12.046 | <0.001 | ||||||||||||||
| 2011—2014 | -4.825 | -5.657~-3.986 | -12.993 | <0.001 | ||||||||||||||
| 2014—2019 | -0.079 | -0.356~0.198 | -0.660 | <0.001 | ||||||||||||||
| 2019—2021 | -2.695 | -3.545~-1.837 | -7.177 | <0.001 | ||||||||||||||
| 感染率 | ||||||||||||||||||
| 0~4岁 | -0.187 | -0.578~0.205 | -0.936 | 0.350 | ||||||||||||||
| 2000—2004 | -7.950 | -8.784~-7.108 | -20.029 | <0.001 | ||||||||||||||
| 2004—2015 | -0.102 | -0.326~0.122 | -1.006 | 0.336 | ||||||||||||||
| 2015—2019 | 8.697 | 7.143~10.272 | 12.753 | <0.001 | ||||||||||||||
| 2019—2021 | -1.503 | -4.298~1.373 | -1.158 | 0.271 | ||||||||||||||
| 5~9岁 | 2.137 | 1.763~2.512 | 11.299 | <0.001 | ||||||||||||||
| 2000—2005 | 4.269 | 3.711~4.830 | 17.960 | <0.001 | ||||||||||||||
| 2005—2010 | 0.913 | 0.150~1.681 | 2.760 | 0.025 | ||||||||||||||
| 2010—2015 | -1.271 | -2.018~-0.519 | -3.887 | 0.005 | ||||||||||||||
| 2015—2019 | 6.852 | 5.577~8.142 | 12.734 | <0.001 | ||||||||||||||
| 2019—2021 | -0.578 | -1.935~1.838 | -0.557 | 0.593 | ||||||||||||||
| 10~14岁 | 0.613 | 0.496~0.731 | 10.280 | <0.001 | ||||||||||||||
| 2000—2005 | -2.427 | -2.593~-2.260 | -33.213 | <0.001 | ||||||||||||||
| 2005—2010 | 1.685 | 1.440~1.930 | 15.969 | <0.001 | ||||||||||||||
| 2010—2015 | -1.644 | -1.881~-1.407 | -15.848 | <0.001 | ||||||||||||||
| 2015—2019 | 6.767 | 6.361~7.175 | 39.586 | <0.001 | ||||||||||||||
| 2019—2021 | -0.565 | -1.321~0.196 | -1.714 | 0.125 | ||||||||||||||
| 15~19岁 | -0.522 | -0.744~-0.299 | -4.575 | <0.001 | ||||||||||||||
| 2000—2005 | -3.110 | -3.427~-2.792 | -22.218 | <0.001 | ||||||||||||||
| 2005—2010 | 0.560 | 0.095~1.028 | 2.779 | 0.024 | ||||||||||||||
| 2010—2015 | -1.934 | -2.388~-1.479 | -9.713 | <0.001 | ||||||||||||||
| 2015—2019 | 3.071 | 2.318~3.829 | 9.513 | <0.001 | ||||||||||||||
| 2019—2021 | -0.156 | -1.610~1.319 | -0.246 | 0.812 | ||||||||||||||
| 20~24岁 | -0.511 | -0.761~-0.260 | -3.989 | <0.001 | ||||||||||||||
| 2000—2005 | -2.550 | -2.908~-2.190 | -16.166 | <0.001 | ||||||||||||||
| 2005—2010 | 0.812 | 0.288~1.339 | 3.578 | 0.007 | ||||||||||||||
| 2010—2015 | -2.296 | -2.804~-1.785 | -10.278 | <0.001 | ||||||||||||||
| 2015—2019 | 2.464 | 1.624~3.312 | 6.814 | <0.001 | ||||||||||||||
| 2019—2021 | -0.007 | -1.641~1.654 | -0.010 | 0.993 | ||||||||||||||
| 死亡率 | ||||||||||||||||||
| 0~4岁 | -14.058 | -14.430~-13.684 | -68.347 | <0.001 | ||||||||||||||
| 2000—2002 | -9.085 | -12.186~-5.875 | -6.040 | <0.001 | ||||||||||||||
| 2002—2011 | -15.577 | -15.896~-15.256 | -98.413 | <0.001 | ||||||||||||||
| 2011—2016 | -9.910 | -10.893~-8.915 | -20.928 | <0.001 | ||||||||||||||
| 2016—2021 | -17.224 | -17.864~-16.579 | -53.614 | <0.001 | ||||||||||||||
| 5~9岁 | -13.030 | -13.629~-12.427 | -39.577 | <0.001 | ||||||||||||||
| 2000—2005 | -12.400 | -14.090~-10.677 | -14.574 | <0.001 | ||||||||||||||
| 2005—2012 | -15.326 | -16.564~-14.070 | -24.227 | <0.001 | ||||||||||||||
| 2012—2021 | -11.557 | -12.258~-10.851 | -33.116 | <0.001 | ||||||||||||||
| 10~14岁 | -11.031 | -11.477~-10.583 | -45.578 | <0.001 | ||||||||||||||
| 2000—2003 | -8.794 | -11.412~-6.099 | -6.780 | <0.001 | ||||||||||||||
| 2003—2015 | -10.910 | -11.259~-10.559 | -63.100 | <0.001 | ||||||||||||||
| 2015—2021 | -12.368 | -13.227~-11.501 | -28.764 | <0.001 | ||||||||||||||
| 15~19岁 | -8.898 | -9.333~-8.460 | -38.099 | <0.001 | ||||||||||||||
| 2000—2010 | -10.539 | -10.942~-10.134 | -52.887 | <0.001 | ||||||||||||||
| 2010—2017 | -6.541 | -7.452~-5.620 | -14.795 | <0.001 | ||||||||||||||
| 2017—2021 | -8.830 | -10.487~-7.142 | -10.808 | <0.001 | ||||||||||||||
| 20~24岁 | -8.174 | -8.786~-7.558 | -25.005 | <0.001 | ||||||||||||||
| 2000—2004 | -9.766 | -10.870~-8.648 | -19.252 | <0.001 | ||||||||||||||
| 2004—2007 | -16.780 | -19.957~-13.477 | -10.882 | <0.001 | ||||||||||||||
| 2007—2013 | -7.783 | -8.582~-6.977 | -21.466 | <0.001 | ||||||||||||||
| 2013—2017 | -2.268 | -4.152~-0.348 | -2.719 | 0.026 | ||||||||||||||
| 2017—2021 | -6.075 | -7.224~-4.911 | -11.741 | <0.001 | ||||||||||||||
| DALYs率 | ||||||||||||||||||
| 0~4岁 | -12.670 | -12.864~-12.475 | -119.238 | <0.001 | ||||||||||||||
| 2000—2002 | -9.786 | -11.377~-8.167 | -12.741 | <0.001 | ||||||||||||||
| 2002—2011 | -14.555 | -14.721~-14.389 | -178.362 | <0.001 | ||||||||||||||
| 2011—2016 | -9.495 | -10.002~-8.984 | -39.031 | <0.001 | ||||||||||||||
| 2016—2021 | -13.490 | -13.834~-13.146 | -80.181 | <0.001 | ||||||||||||||
| 5~9岁 | -10.776 | -11.544~-10.002 | -25.866 | <0.001 | ||||||||||||||
| 2000—2005 | -10.831 | -12.102~-9.543 | -17.586 | <0.001 | ||||||||||||||
| 2005—2015 | -12.584 | -13.095~-12.071 | -50.536 | <0.001 | ||||||||||||||
| 2015—2019 | -5.512 | -8.496~-2.432 | -3.890 | 0.003 | ||||||||||||||
| 2019—2021 | -11.731 | -17.217~-5.882 | -4.280 | 0.001 | ||||||||||||||
| 10~14岁 | -10.412 | -10.752~-10.098 | -61.532 | <0.001 | ||||||||||||||
| 2000—2003 | -8.326 | -10.556~-6.041 | -7.449 | <0.001 | ||||||||||||||
| 2003—2021 | -10.756 | -10.896~-10.614 | -151.746 | <0.001 | ||||||||||||||
| 15~19岁 | -6.730 | -7.094~-6.365 | -34.953 | <0.001 | ||||||||||||||
| 2000—2007 | -9.303 | -9.679~-8.925 | -51.707 | <0.001 | ||||||||||||||
| 2007—2014 | -6.438 | -6.928~-5.945 | -27.858 | <0.001 | ||||||||||||||
| 2014—2019 | -3.449 | -4.394~-2.495 | -7.855 | <0.001 | ||||||||||||||
| 2019—2021 | -6.684 | -9.541~-3.736 | -4.895 | <0.001 | ||||||||||||||
| 20~24岁 | -5.709 | -6.257~-5.159 | -19.800 | <0.001 | ||||||||||||||
| 2000—2004 | -8.958 | -9.923~-7.983 | -20.306 | <0.001 | ||||||||||||||
| 2004—2007 | -12.350 | -15.255~-9.345 | -9.019 | <0.001 | ||||||||||||||
| 2007—2013 | -5.279 | -5.990~-4.562 | -16.593 | <0.001 | ||||||||||||||
| 2013—2019 | -0.906 | -1.650~-0.156 | -2.785 | 0.024 | ||||||||||||||
| 2019—2021 | -4.100 | -7.279~-0.813 | -2.865 | 0.021 | ||||||||||||||
| 年份 | 发病率 | 感染率 | 死亡率 | DALYs率 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | ||||||||||
| 2000 | 96.87 | 62.92 | 79.15 | 33541.89 | 31281.37 | 32422.78 | 13.86 | 7.19 | 10.30 | 468.97 | 285.53 | 374.96 | |||||||||
| 2001 | 93.14 | 59.80 | 75.73 | 33164.73 | 30869.01 | 32027.97 | 13.27 | 6.75 | 9.77 | 443.77 | 265.84 | 352.40 | |||||||||
| 2002 | 89.04 | 56.26 | 71.94 | 32465.41 | 30079.04 | 31284.17 | 12.78 | 6.37 | 9.34 | 423.33 | 244.97 | 331.84 | |||||||||
| 2003 | 84.98 | 52.72 | 68.18 | 31673.69 | 29178.30 | 30438.99 | 12.38 | 5.97 | 8.93 | 403.72 | 223.57 | 311.30 | |||||||||
| 2004 | 81.38 | 49.62 | 64.87 | 31020.96 | 28437.08 | 29742.72 | 11.80 | 5.48 | 8.38 | 380.85 | 202.95 | 289.53 | |||||||||
| 2005 | 78.66 | 47.42 | 62.44 | 30740.24 | 28126.36 | 29466.97 | 10.78 | 4.77 | 7.53 | 347.17 | 176.69 | 259.64 | |||||||||
| 2006 | 76.69 | 45.91 | 60.71 | 30788.32 | 28201.01 | 29507.71 | 9.07 | 3.93 | 6.30 | 302.41 | 150.32 | 224.55 | |||||||||
| 2007 | 75.00 | 44.60 | 59.23 | 30924.38 | 28384.38 | 29666.79 | 7.99 | 3.33 | 5.48 | 271.43 | 130.31 | 199.23 | |||||||||
| 2008 | 73.40 | 43.38 | 57.84 | 31087.61 | 28601.68 | 29856.37 | 7.22 | 2.91 | 4.91 | 249.02 | 116.18 | 181.14 | |||||||||
| 2009 | 71.74 | 42.14 | 56.42 | 31217.35 | 28779.21 | 30009.22 | 6.47 | 2.57 | 4.38 | 227.11 | 104.52 | 164.50 | |||||||||
| 2010 | 69.88 | 40.78 | 54.83 | 31252.77 | 28842.19 | 30507.59 | 5.80 | 2.29 | 3.95 | 207.69 | 94.31 | 149.83 | |||||||||
| 2011 | 67.12 | 38.80 | 52.48 | 31012.35 | 28610.11 | 29820.63 | 5.37 | 2.08 | 3.62 | 193.19 | 86.28 | 138.67 | |||||||||
| 2012 | 63.39 | 36.16 | 49.33 | 30483.30 | 28082.99 | 29292.10 | 4.98 | 1.89 | 3.34 | 179.81 | 79.04 | 128.45 | |||||||||
| 2013 | 59.44 | 33.41 | 46.01 | 29859.87 | 27457.93 | 28667.66 | 4.57 | 1.72 | 3.06 | 165.72 | 71.63 | 117.78 | |||||||||
| 2014 | 56.00 | 31.09 | 43.16 | 29337.27 | 26933.53 | 28144.18 | 4.26 | 1.58 | 2.84 | 154.64 | 65.61 | 109.29 | |||||||||
| 2015 | 53.81 | 29.75 | 41.42 | 29110.34 | 26708.01 | 27918.13 | 4.07 | 1.51 | 2.72 | 147.67 | 62.54 | 104.30 | |||||||||
| 2016 | 52.70 | 29.22 | 40.62 | 29492.05 | 27109.00 | 28310.15 | 3.89 | 1.46 | 2.60 | 141.47 | 60.23 | 100.06 | |||||||||
| 2017 | 51.88 | 28.88 | 40.06 | 30357.88 | 28012.27 | 29196.21 | 3.62 | 1.34 | 2.41 | 133.17 | 56.39 | 94.03 | |||||||||
| 2018 | 51.18 | 28.57 | 39.57 | 31246.40 | 28938.23 | 30105.43 | 3.38 | 1.23 | 2.25 | 126.06 | 52.99 | 88.80 | |||||||||
| 2019 | 50.39 | 28.17 | 39.00 | 31696.74 | 29408.98 | 30567.83 | 3.18 | 1.15 | 2.10 | 119.46 | 50.07 | 84.08 | |||||||||
| 2020 | 49.01 | 27.27 | 37.88 | 31664.19 | 29368.84 | 30533.08 | 3.03 | 1.08 | 2.00 | 114.17 | 47.58 | 80.21 | |||||||||
| 2021 | 46.75 | 26.27 | 36.28 | 31679.16 | 29399.21 | 30557.45 | 2.90 | 1.03 | 1.91 | 108.66 | 45.02 | 76.22 | |||||||||
| 均值 | 67.83 | 40.14 | 53.51 | 31082.59 | 28673.12 | 29889.73 | 7.03 | 3.07 | 4.92 | 241.34 | 121.48 | 180.04 | |||||||||
| 变化率 (%) | -51.74 | -58.25 | -54.16 | -5.55 | -6.02 | -5.75 | -79.08 | -85.67 | -81.46 | -76.83 | -84.23 | -79.67 | |||||||||
| 分类/性别/年份 | APC值 (%) | 95%CI值 (%) | t值 | P值 | AAPC值 (%) | 95%CI值 (%) | t值 | P值 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 发病率 | |||||||||||||||
| 男性 | -3.396 | -3.480~-3.312 | -77.962 | <0.001 | |||||||||||
| 2000—2005 | -4.173 | -4.295~-4.051 | -72.320 | <0.001 | |||||||||||
| 2005—2010 | -2.135 | -2.311~-1.959 | -27.684 | <0.001 | |||||||||||
| 2010—2015 | -5.323 | -5.493~-5.153 | -70.162 | <0.001 | |||||||||||
| 2015—2019 | -1.427 | -1.707~-1.147 | -11.662 | <0.001 | |||||||||||
| 2019—2021 | -3.609 | -4.156~-3.060 | -14.912 | <0.001 | |||||||||||
| 女性 | -4.082 | -4.227~-3.936 | -53.784 | <0.001 | |||||||||||
| 2000—2005 | -5.647 | -5.857~-5.437 | -60.316 | <0.001 | |||||||||||
| 2005—2010 | -2.749 | -3.054~-2.443 | -20.449 | <0.001 | |||||||||||
| 2010—2015 | -6.384 | -6.678~-6.090 | -48.403 | <0.001 | |||||||||||
| 2015—2019 | -1.088 | -1.579~-0.595 | -5.077 | <0.001 | |||||||||||
| 2019—2021 | -3.510 | -4.464~-2.546 | -8.290 | <0.001 | |||||||||||
| 感染率 | |||||||||||||||
| 男性 | -0.288 | -0.421~-0.155 | -4.236 | <0.001 | |||||||||||
| 2000—2005 | -1.860 | -2.052~-1.668 | -22.157 | <0.001 | |||||||||||
| 2005—2010 | 0.492 | 0.214~0.770 | 4.093 | <0.001 | |||||||||||
| 2010—2015 | -1.577 | -1.849~-1.305 | -13.263 | <0.001 | |||||||||||
| 2015—2019 | 2.332 | 1.886~2.780 | 12.164 | <0.001 | |||||||||||
| 2019—2021 | -0.198 | -1.066~0.678 | -0.523 | <0.001 | |||||||||||
| 女性 | -0.317 | -0.488~-0.146 | -3.630 | <0.001 | |||||||||||
| 2000—2005 | -2.270 | -2.515~-2.024 | -21.091 | <0.001 | |||||||||||
| 2005—2010 | 0.696 | 0.340~1.055 | 4.508 | <0.001 | |||||||||||
| 2010—2015 | -1.714 | -2.062~-1.364 | -11.229 | <0.001 | |||||||||||
| 2015—2019 | 2.637 | 2.062~2.215 | 10.692 | <0.001 | |||||||||||
| 2019—2021 | -0.214 | -1.328~0.913 | -0.439 | <0.001 | |||||||||||
| 死亡率 | |||||||||||||||
| 男性 | -7.221 | -7.719~-6.720 | -27.270 | <0.001 | |||||||||||
| 2000—2004 | -3.774 | -5.064~-2.466 | -6.274 | <0.001 | |||||||||||
| 2004—2009 | -11.699 | -12.883~-10.500 | -20.293 | <0.001 | |||||||||||
| 2009—2013 | -8.014 | -9.956~-6.030 | -8.617 | <0.001 | |||||||||||
| 2013—2021 | -5.633 | -6.071~-5.193 | -27.408 | <0.001 | |||||||||||
| 女性 | -8.880 | -9.351~-8.407 | -35.192 | <0.001 | |||||||||||
| 2000—2004 | -6.378 | -7.585~-5.155 | -11.180 | <0.001 | |||||||||||
| 2004—2008 | -15.368 | -17.086~-13.614 | -17.901 | <0.001 | |||||||||||
| 2008—2013 | -9.679 | -10.843~-8.500 | -17.269 | <0.001 | |||||||||||
| 2013—2021 | -6.210 | -6.629~-5.789 | -31.520 | <0.001 | |||||||||||
| DALYs率 | |||||||||||||||
| 男性 | -6.724 | -6.992~-6.455 | -47.447 | <0.001 | |||||||||||
| 2000—2004 | -4.840 | -5.271~-4.407 | -25.192 | <0.001 | |||||||||||
| 2004—2007 | -10.860 | -12.131~-9.571 | -18.461 | <0.001 | |||||||||||
| 2007—2010 | -8.564 | -9.868~-7.242 | -14.377 | <0.001 | |||||||||||
| 2010—2014 | -7.046 | -7.711~-6.376 | -23.465 | <0.001 | |||||||||||
| 2014—2021 | -4.980 | -5.162~-4.798 | -61.386 | <0.001 | |||||||||||
| 女性 | -8.452 | -8.844~-8.058 | -40.325 | <0.001 | |||||||||||
| 2000—2004 | -8.176 | -8.800~-7.551 | -29.014 | <0.001 | |||||||||||
| 2004—2007 | -14.117 | -15.938~-12.256 | -16.371 | <0.001 | |||||||||||
| 2007—2010 | -10.146 | -12.052~-8.199 | -11.509 | <0.001 | |||||||||||
| 2010—2014 | -8.456 | -9.432~-7.469 | -19.008 | <0.001 | |||||||||||
| 2014—2021 | -5.317 | -5.588~-5.045 | -43.980 | <0.001 | |||||||||||
| [1] | World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024. |
| [2] | 苏茜, 夏勇, 逯嘉, 等. 2009—2018年四川省0-14岁儿童肺结核流行特征分析. 中国防痨杂志, 2020, 42(9): 942-947. doi:10.3969/j.issn.1000-6621.2020.09.011. |
| [3] | 刘二勇, 马艳, 李涛, 等. 全国14岁以下儿童肺结核疫情特征分析. 中国防痨杂志, 2014, 36 (12): 1015-1020. |
| [4] | World Health Organization. Global Programme on Tuberculosis & Lung Health. [2025-08-01]. https://data.who.int/dashboards/tuberculosis/tuberculosis-epidemiological-profile?m49=156. |
| [5] | 陶璐秋, 章紫钰, 谭高, 等. 中国1990—2021年5岁以下儿童结核病疾病负担变化趋势. 中国学校卫生, 2024, 45(12):1792-1797. doi:10.16835/j.cnki.1000-9817.2024358. |
| [6] | 戴萌娜, 袭燕, 尹文强, 等. 1990—2019年中国结核病疾病负担现状及趋势分析. 中国慢性病预防与控制, 2022, 30(10):792-797. doi:10.16386/j.cjpccd.issn.1004-6194.2022.10.017. |
| [7] | 赵飞, 裴航, 姚媛媛, 等. 1990—2019年中国与“一带一路”沿线南亚三国结核病疾病负担研究. 中华疾病控制杂志, 2023, 27(2):169-175. doi:10.16462/j.cnki.zhjbkz.2023.02.008. |
| [8] | 曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用. 中国卫生统计, 2019, 36(5):787-791. |
| [9] | 谢煜相, 刘月凤, 黄鹏, 等. 2017—2022年南昌市肺结核疾病负担调查分析. 南昌大学学报(医学版), 2024, 64(4):93-98. doi:10.13764/j.cnki.ncdm.2024.04.017. |
| [10] | 陆伟, 周扬, 刘剑君. 新中国成立70年来我国结核病防治工作的进展与成就. 中华疾病控制杂志, 2019, 23(7):754-757,762. doi:10.16462/j.cnki.zhjbkz.2019.07.003. |
| [11] | 中华人民共和国国家卫生计划生育委员会办公厅, 中华人民共和国教育部办公厅. 关于印发学校结核病防控工作规范(2017版)的通知. 国卫办疾控发〔2017〕22号. 2017-06-26. |
| [12] | 中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国教育部办公厅. 国家卫生健康委办公厅教育部办公厅关于印发中国学校结核病防控指南的通知. 国卫办疾控函〔2020〕910号. 2020-10-16. |
| [13] | 王慧娟, 程瑞霞, 许佳. 肺结核患者服药依从性研究进展. 中国防痨杂志, 2025, 47(9): 1212-1219. doi:10.19982/j.issn.1000-6621.20250173. |
| [14] | 姚晶, 沈鑫, 顾凯侃, 等. 国内外儿童及学校结核病疫情概况. 结核病与肺部健康杂志, 2019, 8(2):142-145. doi:10.3969/j.issn.2095-3755.2019.02.014. |
| [15] | 中国防痨协会. 结核病研究进展报告 (2020). 北京: 人民卫生出版社, 2021: 310. |
| [16] | 梁雪芳, 王志英, 朱志鹏. 学校结核病传播动力学特征与防控策略研究进展. 中国防痨杂志, 2025, 47(S1): 375-379. |
| [17] | 张春华, 陈伟. 儿童结核病流行现状与经济负担研究进展. 结核与肺部疾病杂志, 2022, 3(5): 405-409. doi:10.19983/j.issn.2096-8493.20220131. |
| [18] | 毛俊杰, 鲁佳旺. 结核病传播动力学模型研究进展. 中国感染控制杂志, 2023, 22 (7): 864-868. doi:10.12138/j.issn.1671-9638.20233381. |
| [19] | 王江峡, 许红梅. 儿童结核病的合理用药. 中国实用儿科杂志, 2022, 37(6):444-450. doi:10.19538/j.ek2022060606. |
| [20] | 卓文基, 张晨晨, 陈珣珣, 等. 2014—2020年广东省儿童肺结核耐药特征分析. 中国防痨杂志, 2023, 45(7): 687-692. doi:10.19982/j.issn.1000-6621.20230109. |
| [21] | 程俊杰, 李金梦, 张若英, 等. 儿童结核患者抗结核药物血药浓度影响因素及其安全性分析. 中国现代应用药学, 2024, 41(9):1247-1254. doi:10.13748/j.cnki.issn1007-7693.20232515. |
| [22] | 王前, 王嘉, 李玉红, 等. 重视儿童结核病防治关爱儿童健康. 中国防痨杂志, 2023, 45(1):1-5. doi:10.19982/j.issn.1000-6621.20220462. |
| [23] | 宋媛媛, 李涛, 夏辉, 等. 1997—2003年全国肺结核报告发病流行病学特征. 中国防痨杂志, 2024, 46(10):1198-1208. doi:10.19982/j.issn.1000-6621.20240382. |
| [24] | 梁雪芳, 王志英, 朱志鹏, 等. 特殊人群结核病关怀的研究进展. 中国防痨杂志, 2025, 47(12):1644-1650. doi:10.19982/j.issn.1000-6621.20250251. |
| [25] | 孔雯, 丁晓艳, 竺丽梅, 等. 儿童接种卡介苗3-6年后PPD结果及其对结核潜伏感染的影响. 中国学校卫生, 2019, 40(9):1366-1368. doi:10.16835/j.cnki.1000-9817.2019.09.024. |
| [26] | 梁麟龙, 裴异, 周海依, 等. 2014—2023年湖南省0-14岁儿童肺结核流行特征及变化趋势. 中国防痨杂志, 2025, 47(1):29-35. doi:10.19982/j.issn.1000-6621.20240341. |
| [27] | 周长强. 海南省结核病流行特征、疾病负担及影响因素研究. 青岛:山东大学, 2024. doi:10.27272/d.cnki.gshdu.2024.000246. |
| [28] | 刘二勇, 李惠民, 赵顺英, 等. 儿童结核病流行病学及诊治现状. 中国实用儿科杂志, 2018, 33(6): 423-426. doi:10.19538/j.ek2018060606. |
| [29] | 张梦迪, 王琦琦, 王鑫, 等. 2005—2020年中国60岁及以上老年人群肺结核疾病负担研究. 中国防痨杂志, 2025, 47(3):338-347. doi:10.19982/j.issn.1000-6621.20240508. |
| [30] |
方良梅, 苗瑞芬, 王荣, 等. 1992—2021年中国耐多药结核病疾病负担变化趋势分析. 中国全科医学, 2025, 28(17):2163-2171.
doi: 10.12114/j.issn.1007-9572.2024.0660 |
| [31] | 张馨月, 王瑜, 熊丽蓉. 1990—2021年中国耐多药结核病负担趋势及其危险因素分析. 现代预防医学, 2025, 52(9):1544-1549. doi:10.20043/j.cnki.MPM.202412525. |
| [1] | Pharmaceutical Professional Branch of Chinese Antituberculosis Association. Expert consensus on therapy and drug monitoring clinical application of anti-tuberculosis drug (updated in 2025) [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 167-187. |
| [2] | Fu Xuwen, He Weiyaozhen, Li Xiang. Imaging manifestations of male reproductive system tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 188-196. |
| [3] | Su Wei, Bai Xinyu, Maiwulajiang Yimamu, Keyoumu Wubulikasimu, Diermulati Tusun, Lai Fuli, Mirenisha Abudurexiti, Xirizhati Mamuti, Zhou Linjun, Huang Fei. Survival status and influencing factors analysis of patients with rifampicin-resistant pulmonary tuberculosis in Kashgar Prefecture, Xinjiang Uygur Autonomous Region, 2013—2022 [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 197-205. |
| [4] | Wu Xiaoying, He Gang, Cai Xiaoting, He Liqian, Deng Hong, He Liyan. Analysis on the prognostic outcome model of elderly pulmonary tuberculosis patients with comorbidities based on the Chinese multimorbidity-weighted index [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 206-216. |
| [5] | Zhu Shiyu, Song Canlei, Zhang Rui, Hao Yanxing, Zhu Weitao, Gao Xia. Research on the construction of social support indicator system for tuberculosis based on Delphi method [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 217-222. |
| [6] | Xu Liangrun, Yang Mingying, Guo Yingwu, Wang Yun, Xu Jingjing, Hou Juyan, Ma Yunhong. A qualitative study on motivational factors and barriers to pulmonary tuberculosis treatment among initial treated smear-positive pulmonary tuberculosis patients and their families based on the Health Belief Model [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 223-229. |
| [7] | Liu Shuya, Zhang Ting, Wang Qingya, Fan Jun, Wang Ni. Analysis of close contacts screening situation and time changing trends of pulmonary tuberculosis patients in Chongqing from 2015 to 2024 [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 230-237. |
| [8] | Cai Liping, Chen Danping, Tang Jing, Jiang Sisi, Wu Ying, Wang Xiaomei. Construction of a discharge preparation service protocol for new drug-susceptible pulmonary tuberculosis patients based on the Timing Theory [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 238-246. |
| [9] | Lin Weibing, Shi Yiheng, Guo Yanling, Ma Shang, Yang Bin, Long Sibo, Zheng Maike, Sun Yong, Zhao Yan, Wang Guirong. Analysis of drug resistance patterns in 241 patients with lymph node tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 247-255. |
| [10] | Su Ben, Qiu Lei, Zhou Rui, Chen Tao, Chen Yuxian, Cui Jie, Xia Liuyuan, Zhang Shaoyan, Lu Zhenhui. Analysis of usage characteristics of traditional Chinese medicine compound prescriptions for treating pulmonary tuberculosis based on the Chinese Patent Publication and Announcement Network [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 274-281. |
| [11] | Wang Xueyu, Chu Naihui, Nie Wenjuan. Research progress on the anti-Mycobacterium tuberculosis activity of sitafloxacin [J]. Chinese Journal of Antituberculosis, 2026, 48(2): 299-303. |
| [12] | Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences , Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University , Chinese Antituberculosis Association , Editorial Board of the Chinese Journal of Antituberculosis . Expert consensus on TCM syndrome differentiation, treatment principles, formulas, and herbs for latent tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 1-8. |
| [13] | Chen Lina, Ding Liqi, He Yan, Chen Danping. Analysis of current status of self-discipline of pulmonary tuberculosis patients and its influencing factors [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 113-120. |
| [14] | Yu Zhou, Chen Lina, Yang Rongjing, Shang Xuan, Xiao Guosu, Zhang Xianming, Huang Niwen. Hirudin ameliorates tuberculous pleural fibrosis in mice by regulating the Nrf2/HO-1 signaling pathway [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 131-138. |
| [15] | Fan Weixiao, Zhou Ke, Liu Jiayun. Identification of efferocytosis-related core genes in active tuberculosis patients based on GEO database [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 139-147. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.